Additionally, it was recently reported that IL-4 controls monocyte and macrophage immunosuppression in NSCLC, and that the relevant site of IL-4 signaling is not the tumor itself, but the bone marrow, where it drives pro tumorigenic myelopoiesis (53). This evidence concerns the gene IL4 and neoplasm.